Alectinib ( INN, marketed as Alecensa) is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small-cell lung cancer (NSCLC). It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.
Specification/Additional Details
- 4 pack x 7 blister x 8 capsules
- Alecensa
- Alectinib
- Roche
- Capsule
Reviews
There are no reviews yet.